Literature DB >> 18070852

Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study.

Nishant Goyal1, S Haque Nizamie, Pushpal Desarkar.   

Abstract

The potential effect of repetitive transcranial magnetic stimulation (rTMS) on core positive and negative symptoms in schizophrenia has not yet been clearly established. The aim of this study was to examine the efficacy of adjuvant 10 Hz, suprathreshold left prefrontal rTMS in negative symptoms of schizophrenia in a double-blind sham-controlled design. Additionally, our study also investigated the suitability of applying the same stimulus condition on positive symptoms. Ten right-handed schizophrenia patients received sham or active 10 Hz suprathreshold rTMS to the left dorsolateral prefrontal cortex with psychopathology, depression and global improvement ratings before and after rTMS sessions. Compared to sham, active rTMS significantly improved negative symptoms, irrespective of change in depressive symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 18070852     DOI: 10.1176/jnp.2007.19.4.464

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  16 in total

1.  An examination of patient-identified goals for treatment in a first-episode programme in Chennai, India.

Authors:  Srividya N Iyer; Ramamurti Mangala; Jeyagurunathan Anitha; Rangaswamy Thara; Ashok K Malla
Journal:  Early Interv Psychiatry       Date:  2011-09-27       Impact factor: 2.732

2.  Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis.

Authors:  Chuan Shi; Xin Yu; Eric F C Cheung; David H K Shum; Raymond C K Chan
Journal:  Psychiatry Res       Date:  2013-12-21       Impact factor: 3.222

Review 3.  Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date.

Authors:  Jonathan C Cole; Carolyn Green Bernacki; Amanda Helmer; Narsimha Pinninti; John P O'reardon
Journal:  Innov Clin Neurosci       Date:  2015 Jul-Aug

Review 4.  The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis.

Authors:  Rasmus Lorentzen; Tuan D Nguyen; Alexander McGirr; Fredrik Hieronymus; Søren D Østergaard
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-09

5.  Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia.

Authors:  Catarina Freitas; Felipe Fregni; Alvaro Pascual-Leone
Journal:  Schizophr Res       Date:  2009-01-11       Impact factor: 4.939

Review 6.  Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions.

Authors:  Stephen J Brandt; Halimah Y Oral; Carla Arellano-Bravo; Martin H Plawecki; Tom A Hummer; Michael M Francis
Journal:  Neurotherapeutics       Date:  2021-04-12       Impact factor: 7.620

7.  Repetitive transcranial magnetic stimulation in psychiatry.

Authors:  Biswa Ranjan Mishra; Sukanto Sarkar; Samir Kumar Praharaj; Varun S Mehta; Shreyansh Diwedi; S Haque Nizamie
Journal:  Ann Indian Acad Neurol       Date:  2011-10       Impact factor: 1.383

8.  Repetitive Transcranial Magnetic Stimulation in the Treatment of depression: A Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Anand Lingeswaran
Journal:  Indian J Psychol Med       Date:  2011-01

9.  Identifying persistent negative symptoms in first episode psychosis.

Authors:  Cindy L Hovington; Michael Bodnar; Ridha Joober; Ashok K Malla; Martin Lepage
Journal:  BMC Psychiatry       Date:  2012-12-06       Impact factor: 3.630

Review 10.  Transcranial magnetic stimulation (TMS) for schizophrenia.

Authors:  Nadine Dougall; Nicola Maayan; Karla Soares-Weiser; Lisa M McDermott; Andrew McIntosh
Journal:  Cochrane Database Syst Rev       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.